美女免费一级视频在线观看

    1. <form id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></form>
      <address id=BiMYPaeIF><nobr id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></nobr></address>

      PatientPoint is bringing in a new partner familiar with the healthcare world. 

      Last week, Advent International signed a definitive agreement to acquire PatientPoint, with the conviction to be part of the rapidly growing point-of-care market. 

      Advent said that the company acquired the group from an investor group led by L Catterton and Littlejohn & Co, which have been invested in the company since 2007 and 2019 respectively. PatientPoint president Sean Slovenski told MM+M that it’s been about seven years since the company looked for a new partner and this change is part of a normal investing lifecycle. 

      As the biggest player in the POC marketing space, Slovenski said that the team picked Advent to be its private equity partner because it was “a natural fit.”

      “The mission, the culture, the experience — it all aligned,” said Slovenski. “As the biggest company in the space, we get to choose who we want to work with, and it took a lot of time in making this decision.”

      The new investment comes at a time when PatientPoint is at a stage of reinvention. Since its Futurama event earlier this summer, the company has hinted that it’s planning to dig into its expertise to expand its capabilities and were looking for a player to complement them. 

      “We cross so many different sectors in healthcare, physician related, patient related, pharmaceutical and retail related, and finding a company that has an interest in all of those, not just the segment they’re in, is actually a little harder,” said Slovenski. “And with a private equity firm, you get to live across all these areas that we impact. So it allows us to actually have a broader vision, mission and reach.”

      He said that while Advent’s current healthcare portfolio was a plus, the team was drawn to the company specifically because of its experience in industries beyond healthcare. 

      “When you look at Advent and their investments over the last 40 some years and their current portfolio companies, they span across multiple industries. So they understand the customer,” said Slovenski, adding Advent has experience in retail, pharmaceutical and life science. 

      The international private equity firm currently works with a range of life sciences and pharma companies like Simtra BioPharma Solutions, Iodine, Cohance Lifesciences, Mediq, GS Capsule and Apollo HealthCo. 

      Looking into the future, Slovenski shared that the new deal will allow PatientPoint to expand its vision and support the launch of new products. 

      “You’re going to see us applying artificial intelligence and other new technologies to make that content even more personalized, to make it more targeted to the individual, so that we can get an even better outcome for the patient and for the doctor,” said Slovenski. 

      He also added that the company will be adding new capabilities and AI to reach and target patients outside of the doctor’s walls.

      “The thing that gets me most excited is when you can have a mass, scalable difference in people’s lives, and do it in an incredibly effective and efficient way, and that’s where we are going,” said Slovenski. 

      Slovenski said the deal is expected to close within the next 30 to 60 days.